Persson Magnus has filed 4 insider transactions across 1 company since December 2022.
Most recent transaction: a grant/award of 3334 shares of Avalo Therapeutics, Inc. ($AVTX) on December 20, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 20, 2023 | Avalo Therapeutics, Inc. | $AVTX | Persson Magnus | Director | A | Stock Option (Right to Buy) | 3334 | $0.00 | 3,334.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Avalo Therapeutics, Inc. | $AVTX | Persson Magnus | Director | A | Stock Option (Right to Buy) | 28308 | $0.00 | 28,308.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | Avalo Therapeutics, Inc. | $AVTX | Persson Magnus | Director | A | Stock Option (Right to Buy) | 7222 | $0.00 | 7,222.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2022 | Avalo Therapeutics, Inc. | $AVTX | Persson Magnus | Director | A | Stock Option (Right to Buy) | 2536 | $0.00 | 2,536.0000 | 0 | 9999.99% | 0.00% |